V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10435529 | 10033050 | 1.61 | 58.6 | Palliative (P) | 2019-09-23 | 2019-09-24 | IBRUTINIB | 02 | N | IBRUTINIB | 101550564 |
| 10435537 | 10033051 | null | null | null | 2019-04-02 | 2019-04-15 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 101334905 |
| 10435563 | 10033052 | 1.76 | 65 | 03 | 2017-06-10 | 2017-07-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100895160 |
| 10435565 | 10033053 | 1.6 | 42 | Palliative (P) | 2017-01-04 | 2017-01-04 | Capecitabine | 02 | null | CAPECITABINE | 100707883 |
| 10435569 | 10033054 | 1.63 | 105 | Curative (C) | 2017-02-17 | 2017-03-08 | Rituximab | 02 | N | RITUXIMAB | 100965586 |
| 10435587 | 10033055 | 1.8 | 58.6 | Adjuvant (A) | 2017-07-10 | 2017-07-11 | IBRUTINIB | 02 | N | IBRUTINIB | 100708198 |
| 10435592 | 10033056 | 1.65 | 69.1 | Palliative (P) | 2018-05-08 | 2018-05-08 | CHOP R | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101776815 |
| 10435600 | 10033057 | 1.77 | 57 | 03 | 2016-01-15 | 2016-01-15 | CAPECITABINE + OXALIPLATIN | 02 | N | IBRUTINIB | 100908000 |
| 10435616 | 10033058 | 1.58 | 65 | Adjuvant (A) | 2020-01-11 | 2020-01-23 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100761649 |
| 10435617 | 10033059 | null | 73.4 | null | 2021-12-21 | 2021-12-21 | Capecitabine | 02 | null | CAPECITABINE | 101475054 |
| 10435625 | 10033060 | 1.75 | 72.1 | Palliative (P) | 2018-12-24 | 2018-12-24 | IBRUTINIB | N | N | IBRUTINIB | 100313308 |
| 10435628 | 10033061 | 1.68 | null | Disease modification (D) | 2018-06-18 | 2018-06-29 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101774872 |
| 10435634 | 10033062 | 1.65 | 73.6 | 03 | 2018-08-02 | 2018-08-25 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101243363 |
| 10435640 | 10033063 | 1.78 | 90 | null | 2016-02-05 | 2016-02-19 | Capecitabine + Oxaliplatin 21day | 02 | null | IBRUTINIB | 101568002 |
| 10435676 | 10033064 | 1.58 | 80 | Palliative (P) | 2016-10-25 | 2016-11-09 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100062958 |
| 10435689 | 10033065 | 1.7 | 0 | Palliative (P) | 2018-06-03 | 2018-06-03 | IBRUTINIB | 02 | N | IBRUTINIB | 101740959 |
| 10435698 | 10033066 | 1.83 | 88.4 | Curative (C) | 2019-07-25 | 2019-08-16 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 101512084 |
| 10435706 | 10033067 | 1.71 | 103 | Adjuvant (A) | 2019-09-05 | 2019-09-14 | Rituximab | 02 | N | RITUXIMAB | 100297215 |
| 10435710 | 10033068 | 1.62 | 84.3 | null | 2017-12-18 | 2017-12-27 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100418300 |
| 10435731 | 10033069 | 1.59 | 89 | Palliative (P) | 2016-12-25 | 2017-01-10 | Capecitabine | 02 | null | CAPECITABINE | 101156852 |
| 10435765 | 10033070 | 1.72 | 50.6 | 03 | null | 2017-06-18 | CHOP R | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100975303 |
| 10435769 | 10033071 | 1.61 | 49.7 | 03 | 2015-07-04 | 2015-07-07 | Capecitabine + Oxaliplatin 14day | N | N | CAPECITABINE + OXALIPLATIN | 100670156 |
| 10435795 | 10033072 | 1.7 | 71 | 03 | 2017-03-10 | 2017-03-18 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100345746 |
| 10435797 | 10033073 | 1.67 | 75.4 | Palliative (P) | 2017-06-18 | 2017-06-30 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100443122 |
| 10435801 | 10033074 | 1.52 | 84.2 | 03 | 2018-08-02 | 2018-08-15 | Capecitabine | N | N | CAPECITABINE | 100623312 |
| 10435808 | 10033075 | 1.65 | 85.5 | Curative (C) | 2016-03-13 | 2016-03-26 | CAPECITABINE + OXALIPLATIN | N | Y | RITUXIMAB | 101406176 |
| 10435812 | 10033076 | 1.77 | 93 | null | 2021-07-08 | 2021-07-08 | IBRUTINIB | 02 | null | IBRUTINIB | 101047277 |
| 10435815 | 10033077 | 1.75 | 51.6 | null | 2016-08-04 | 2016-08-04 | Rituximab (Maintenance) | 02 | null | RITUXIMAB | 101399067 |
| 10435819 | 10033078 | 1.6 | null | 03 | 2018-01-08 | 2018-01-22 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101541931 |
| 10435822 | 10033079 | 1.56 | 89 | Curative (C) | 2018-05-30 | 2018-06-20 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101657649 |
| 10435830 | 10033080 | 1.88 | 85.8 | Palliative (P) | 2018-04-09 | 2018-04-09 | IBRUTINIB | 02 | N | IBRUTINIB | 101133883 |
| 10435834 | 10033081 | null | 84.2 | null | null | 2019-05-28 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101828462 |
| 10435835 | 10033082 | 1.65 | 84 | Palliative (P) | 2015-09-25 | 2015-09-27 | IBRUTINIB | 02 | N | IBRUTINIB | 100118930 |
| 10435847 | 10033083 | 0 | 81.5 | Adjuvant (A) | 2019-07-31 | 2019-09-02 | Rituximab | 02 | N | RITUXIMAB | 101252580 |
| 10435856 | 10033084 | 1.66 | 106 | null | 2021-03-03 | 2021-03-03 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100620424 |
| 10435868 | 10033085 | 1.79 | 76 | Adjuvant (A) | 2021-04-02 | 2021-04-14 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101833853 |
| 10435891 | 10033086 | 1.73 | 77.7 | null | 2022-02-20 | 2022-02-22 | Rituximab | 02 | null | RITUXIMAB | 100086591 |
| 10435905 | 10033087 | 1.6 | 87 | Adjuvant (A) | 2017-07-24 | 2017-08-12 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101101129 |
| 10435920 | 10033088 | 1.7 | 59 | Palliative (P) | 2019-06-09 | 2019-06-23 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101107859 |
| 10435943 | 10033089 | 1.7 | 81 | Curative (C) | null | null | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100865986 |
| 10435952 | 10033090 | 1.67 | 70.5 | Adjuvant (A) | 2016-07-06 | 2016-07-19 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101869470 |
| 10435953 | 10033091 | 1.66 | 76.4 | Palliative (P) | 2018-07-30 | 2018-08-11 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 100703577 |
| 10436001 | 10033092 | 1.62 | 84 | Adjuvant (A) | 2016-06-07 | 2016-07-03 | Capecitabine + Oxaliplatin 21day | 02 | Y | CAPECITABINE + OXALIPLATIN | 101769181 |
| 10436010 | 10033093 | null | 79.2 | null | 2021-06-28 | 2021-06-28 | IBRUTINIB | 02 | null | IBRUTINIB | 100671256 |
| 10436014 | 10033094 | 1.71 | 0 | 02 | 2017-10-19 | 2017-10-23 | Capecitabine | 02 | N | CAPECITABINE | 100198626 |
| 10436017 | 10033095 | 1.65 | 62.6 | Palliative (P) | 2017-05-12 | 2017-05-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100901499 |
| 10436044 | 10033096 | null | 65.2 | Palliative (P) | 2018-02-22 | 2018-03-08 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 101072729 |
| 10436058 | 10033097 | 1.72 | null | Palliative (P) | 2018-10-31 | 2018-11-01 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100202015 |
| 10436065 | 10033098 | 1.58 | 82.1 | 03 | 2018-10-05 | 2018-10-12 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100315899 |
| 10436066 | 10033099 | 1.67 | 64 | Palliative (P) | 2019-07-01 | 2019-10-03 | IBRUTINIB | 02 | N | IBRUTINIB | 100290479 |